11 000 ‘medics’ face fees axe – South Africa 11 057 health practitioners have not paid their license fees for the year and will be “struck off”.
Archive | October, 2006
Latest Update – More Bad News For The Powered Wheelchair Industry AND The Powered Wheelchair Consumer
Following on from the report yesterday on the new dramatic cut in CMS reimbursement for power chairs: More Bad News For The Powered Wheelchair Industry AND The Powered Wheelchair Consumer RAMP – Restore Access to Mobility Partnership issued the following statement: Huge Cuts in Medicare Mobility Equipment Prices Will Restrict Access for Medicare Beneficiaries (US [...]
Clinical and Angiographic Outcomes After Placement of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions
American Journal of Cardiology – Clinical and Angiographic Outcomes After Placement of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions In this recently published clinical trial by Cheol Whan Lee,
Innovation Does Not Always Help – Germany -See You At RehaCare
It seems to be common sense that innovation is one of the most intelligent ways to flee the price war in the rehab industry. In two weeks we all will see a lot of innovative products at Europe’s biggest rehab show in Duesseldorf. But is the common sense also proven truth? I doubt as far [...]
Health Affairs Blog
Health Affairs Blog Health Affairs has entered the blogosphere as a new means of engaging readers in the health policy debate
More Bad News For The Powered Wheelchair Industry AND The Powered Wheelchair Consumer
Just last week RAMP – Restore Access to Mobility Partnership – who’s members comprise American Association for Homecare; Invacare Corporation; the MED Group; Mobility Products Unlimited, LLC; and Pride Mobility issued a press release stating among other things RAMP welcomes the additional assurances from CMS that down-coding will not occur, but we emphasize that several [...]
Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System
Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System “XIENCE V showed statistically significant superiority to the TAXUS® paclitaxel-eluting coronary stent system”. Related post here
Blood Glucose Monitoring Market Gets a Bit Crowded
Blood Glucose Monitoring Market Gets a Bit Crowded -MDL Newsletter. Not crowded enough perhaps. With diabetes growing at an alarming rate the best the industry could come up with in this day an age is invasive instruments
Follow @sibaya_com on Twitter
